Discontinuation report PMS-NYSTATIN SUSPENSION 100000 UNIT/ML
Report ID | 135474 |
Drug Identification Number | 00792667 |
Brand name | PMS-NYSTATIN SUSPENSION 100000 UNIT/ML |
Common or Proper name | NYSTATIN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | NYSTATIN |
Strength(s) | 100000UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 48mL |
ATC code | A07AA |
ATC description | INTESTINALANTIINFECTIVES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-03-10 |
Remaining supply date | 2021-03-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Demand transferred to 5760626677 pms-NYSTATIN 100,000 U/mL SUSP 100mL and 5760626678 pms-NYSTATIN SUSP 100,000 U/mL 500mL. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-03-11 | French | Compare |
v1 | 2021-03-11 | English | Compare |
Showing 1 to 2 of 2